David B. Johnston
Treasurer presso AVEO Securities Corp.
Profilo
David B.
Johnston is currently the Treasurer at AVEO Securities Corp.
He previously worked as a Director at KeraLink International, Inc., a Principal at Ford Motor Co. and Lotus Development Corp., the Senior Vice President-Finance at Genzyme Corp., the Chief Financial Officer at Genzyme Biosurgery Corp., and the Chief Financial Officer at AVEO Pharmaceuticals, Inc. He was also the Chief Financial Officer & Executive Vice President at ImmunoGen, Inc. from 2013 to 2018.
Additionally, he holds an MBA from the University of Michigan and an undergraduate degree from Washington & Lee University.
Posizioni attive di David B. Johnston
| Società | Posizione | Inizio |
|---|---|---|
AVEO Securities Corp.
 AVEO Securities Corp. Pharmaceuticals: MajorHealth Technology Part of LG Chem Ltd., AVEO Securities Corp. is a company based in Cambridge, MA. | Treasurer | - |
Precedenti posizioni note di David B. Johnston
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOGEN, INC. | Direttore Finanziario/CFO | 26/11/2018 |
| IMMUNOGEN, INC. | Direttore Finanziario/CFO | 11/11/2014 |
| AVEO PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 30/12/2013 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2007 |
Genzyme Biosurgery Corp.
 Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | Direttore Finanziario/CFO | - |
Formazione di David B. Johnston
| University of Michigan | Masters Business Admin |
| Washington & Lee University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FORD MOTOR COMPANY | Consumer Durables |
| Aziende private | 8 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Lotus Development Corp.
 Lotus Development Corp. Packaged SoftwareTechnology Services Lotus Development Corp. was an American software company. The company was famous for their groundbreaking Lotus 1-2-3 spreadsheet application, which was the killer application in the early days of the IBM PC which helped spread the adoption of the PC. The company also provided one of the more powerful groupware systems, Lotus Notes. The company was headquartered in Cambridge, MA | Technology Services |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
McCue Corp.
 McCue Corp. Miscellaneous ManufacturingProducer Manufacturing McCue Corp. provides asset protection and damage prevention solutions. It offers bumpers, sales area corners and rails, back rooms, beans, and outdoor products for retail customers; and bollards, rack protection, and rails and barriers for warehouses and material handling applications. The company was founded by David McCue in 1988 and is headquartered in Salem, MA. | Producer Manufacturing |
KeraLink International, Inc.
 KeraLink International, Inc. Medical/Nursing ServicesHealth Services KeraLink International, Inc. operates as a non-governmental network of eye and tissue banks. It also provides ocular tissues used in transplant surgeries. The company was founded in 1962 and is headquartered in Baltimore, MD. | Health Services |
AVEO Securities Corp.
AVEO Securities Corp. Pharmaceuticals: MajorHealth Technology Part of LG Chem Ltd., AVEO Securities Corp. is a company based in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- David B. Johnston
